Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 15, 2025
Reporting period
Not applicable
Filed with the SEC
Oct 16, 2025
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000785161-25-000108
Filed / recorded
Oct 16, 2025, 7:44 PM UTC
Added to OQRO
Oct 6, 2026, 7:37 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Encompass Health Corp
Issuer CIK
785161
Ticker
EHC
Reporting person
Edward M Iii Christie
Relationship
Director
Security
Encompass Health Common Stock
Table
Non-derivative (Table I)
Transaction date
Oct 15, 2025
Transaction code
A
Shares / units
7
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
6,681
Ownership form
Direct
Amendment
No
Footnotes from the filing
Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2025, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $123.65. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.